Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers nPulse System, a novel Nanosecond Pulsed-Field Ablation delivery platform to treat benign lesions of the skin; nPulse Vybrance Percutaneous Electrode system...
Q1 2026
May 14, 2026
FY 2025
Feb 19, 2026
Q4 2025
Q3 2025
Nov 5, 2025
Q2 2025
Aug 12, 2025